Hashimoto disease is an autoimmune disorder that affects the thyroid gland. It is a chronic condition that can cause a variety of symptoms, including fatigue, weight gain, depression, and dry skin. The exact cause of Hashimoto disease is unknown, but it is believed to be linked to genetics and environmental factors. Treatment for Hashimoto disease typically involves medications and lifestyle adjustments to help manage the symptoms. In this article, we will explore the causes and treatments of Hashimoto disease.
Hashimoto disease is an autoimmune disorder in which the body’s immune system mistakenly attacks the thyroid gland. This causes the thyroid gland to become inflamed and unable to produce the hormones needed to regulate metabolism, heart rate, and body temperature. Over time, this can lead to an underactive thyroid, or hypothyroidism. Hashimoto disease is the most common cause of hypothyroidism in the United States. It is estimated that up to 2% of the population has the disease, and it is more common in women than men. It can occur at any age, but it is more likely to occur in people over the age of 40.
The exact cause of Hashimoto disease is unknown, but it is believed to be linked to genetics and environmental factors. Genetics plays a role in the development of the disease, as it is more common in people who have a family history of the disorder. Environmental factors, such as exposure to certain viruses or toxins, may also play a role in the development of the disorder.
The symptoms of Hashimoto disease can vary from person to person, but they typically include fatigue, weight gain, depression, dry skin, and constipation. Other symptoms may include muscle aches, joint pain, and an enlarged thyroid gland, known as a goiter.
Hashimoto disease is typically diagnosed through a physical exam and a blood test. The blood test measures the levels of thyroid hormones and antibodies in the body. If the levels of these hormones and antibodies are abnormal, it is likely that the patient has Hashimoto disease.
Treatment for Hashimoto disease typically involves medications and lifestyle adjustments to help manage the symptoms. Medications, such as levothyroxine, can help to replace the hormones that the thyroid is not producing. In addition, lifestyle adjustments, such as eating a balanced diet, getting regular exercise, and reducing stress, can help to manage the symptoms of the disease.
Hashimoto disease is an autoimmune disorder that affects the thyroid gland. It is a chronic condition that can cause a variety of symptoms, including fatigue, weight gain, depression, and dry skin. The exact cause of Hashimoto disease is unknown, but it is believed to be linked to genetics and environmental factors. Treatment for Hashimoto disease typically involves medications and lifestyle adjustments to help manage the symptoms. By understanding the causes and treatments of Hashimoto disease, doctors can provide the best possible care for their patients.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation